APA 6th Edition Đaković Rode, O., Jemeršić, L. & Vince, A. (2016). HEPATITIS E U HRVATSKOJ – SMJERNICE ZA DIJAGNOSTIKU I LIJEČENJE. Liječnički vjesnik, 138 (9-10), 0-0. Retrieved from https://hrcak.srce.hr/172892
MLA 8th Edition Đaković Rode, Oktavija, et al. "HEPATITIS E U HRVATSKOJ – SMJERNICE ZA DIJAGNOSTIKU I LIJEČENJE." Liječnički vjesnik, vol. 138, no. 9-10, 2016, pp. 0-0. https://hrcak.srce.hr/172892. Accessed 21 Nov. 2019.
Chicago 17th Edition Đaković Rode, Oktavija, Lorena Jemeršić and Adriana Vince. "HEPATITIS E U HRVATSKOJ – SMJERNICE ZA DIJAGNOSTIKU I LIJEČENJE." Liječnički vjesnik 138, no. 9-10 (2016): 0-0. https://hrcak.srce.hr/172892
Harvard Đaković Rode, O., Jemeršić, L., and Vince, A. (2016). 'HEPATITIS E U HRVATSKOJ – SMJERNICE ZA DIJAGNOSTIKU I LIJEČENJE', Liječnički vjesnik, 138(9-10), pp. 0-0. Available at: https://hrcak.srce.hr/172892 (Accessed 21 November 2019)
Vancouver Đaković Rode O, Jemeršić L, Vince A. HEPATITIS E U HRVATSKOJ – SMJERNICE ZA DIJAGNOSTIKU I LIJEČENJE. Liječnički vjesnik [Internet]. 2016 [cited 2019 November 21];138(9-10):0-0. Available from: https://hrcak.srce.hr/172892
IEEE O. Đaković Rode, L. Jemeršić and A. Vince, "HEPATITIS E U HRVATSKOJ – SMJERNICE ZA DIJAGNOSTIKU I LIJEČENJE", Liječnički vjesnik, vol.138, no. 9-10, pp. 0-0, 2016. [Online]. Available: https://hrcak.srce.hr/172892. [Accessed: 21 November 2019]
Abstracts Hepatitis E is attributed great attention as an emerging worldwide-distributed zoonosis. The clinical presentation varies from severe fulminant in underdeveloped to milder forms of diagnostically unrecognized hepatitis cases in developed countries. Chronic hepatitis E is more often described in subjects with transplanted solid organs and HIV disease. The diagnosis of hepatitis E is established by determination of anti-HEV IgM and IgG with Western blot confirmation and detection of HEV RNA. In Croatia, the first case of indigenous disease caused by HEV genotype 3 (HEV-3) was detected in 2012. In this paper we present current knowledge on hepatitis E supplemented by own results obtained at the University Hospital for Infectious Diseases in Zagreb and guidelines for diagnosis and treatment of immunocompetent and immunocompromised individuals. In the period from 2011-2014, HEV was tested in 1107 patients, of whom 117 (10.6%) had anti-HEV antibodies. Acute HEV infection was diagnosed in 25 (2.3%) patients. Considering the prevalence of antibodies we can conclude that HEV diagnostics should be included in the diagnostic panel for patients with elevated aminotransferases.